Abstract:Epithelial-to-mesenchymal transitions (EMTs) are phenotypic plasticity processes that confer migratory and invasive properties to epithelial cells during development, wound-healing, fibrosis and cancer<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>. EMTs are driven by SNAIL, ZEB and TWIST transcription factors<a href="/articles/s41586-019-1897-5#ref-CR5">5</a>,<a href="/articles/s41586-019-1897-5#ref-CR6">6</a> together with microRNAs that balance this regulatory network<a href="/articles/s41586-019-1897-5#ref-CR7">7</a>,<a href="/articles/s41586-019-1897-5#ref-CR8">8</a>. Transforming growth factor β (TGF-β) is a potent inducer of developmental and fibrogenic EMTs<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR9">9</a>,<a href="/articles/s41586-019-1897-5#ref-CR10">10</a>. Aberrant TGF-β signalling and EMT are implicated in the pathogenesis of renal fibrosis, alcoholic liver disease, non-alcoholic steatohepatitis, pulmonary fibrosis and cancer<a href="/articles/s41586-019-1897-5#ref-CR4">4</a>,<a href="/articles/s41586-019-1897-5#ref-CR11">11</a>. TGF-β depends on RAS and mitogen-activated protein kinase (MAPK) pathway inputs for the induction of EMTs<a href="#ref-CR12">12</a>,<a href="#ref-CR13">13</a>,<a href="#ref-CR14">14</a>,<a href="#ref-CR15">15</a>,<a href="#ref-CR16">16</a>,<a href="#ref-CR17">17</a>,<a href="#ref-CR18">18</a>,<a href="/articles/s41586-019-1897-5#ref-CR19">19</a>. Here we show how these signals coordinately trigger EMTs and integrate them with broader pathophysiological processes. We identify RAS-responsive element binding protein 1 (RREB1), a RAS transcriptional effector<a href="/articles/s41586-019-1897-5#ref-CR20">20</a>,<a href="/articles/s41586-019-1897-5#ref-CR21">21</a>, as a key partner of TGF-β-activated SMAD transcription factors in EMT. MAPK-activated RREB1 recruits TGF-β-activated SMAD factors to SNAIL. Context-dependent chromatin accessibility dictates the ability of RREB1 and SMAD to activate additional genes that determine the nature of the resulting EMT. In carcinoma cells, TGF-β–SMAD and RREB1 directly drive expression of SNAIL and fibrogenic factors stimulating myofibroblasts, promoting intratumoral fibrosis and supporting tumour growth. In mouse epiblast progenitors, Nodal–SMAD and RREB1 combine to induce expression of SNAIL and mesendoderm-differentiation genes that drive gastrulation. Thus, RREB1 provides a molecular link between RAS and TGF-β pathways for coordinated induction of developmental and fibrogenic EMTs. These insights increase our understanding of the regulation of epithelial plasticity and its pathophysiological consequences in development, fibrosis and cancer.

Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer

PRMT5-mediated histone methylation regulates alternative splicing via MECP2-PTBP1 to promote EMT in breast cancer hypoxia

Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1

AEP-cleaved DDX3X Induces Alternative RNA Splicing Events to Mediate Cancer Cell Adaptation in Harsh Microenvironments.

Alternative splicing in EMT and TGF-β signaling during cancer progression

Upregulation of MiR-205 under hypoxia promotes epithelial–mesenchymal transition by targeting ASPP2

Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC

A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic Cancer

SPSB1-mediated HnRNP A1 Ubiquitylation Regulates Alternative Splicing and Cell Migration in EGF Signaling

Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment

Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer

TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance

Epigenetic coordination of transcriptional and translational programs in hypoxia

Hypoxia influences polysome distribution of human ribosomal protein S12 and alternative splicing of ribosomal protein mRNAs

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells

TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1

Epithelial–Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress

Atypical Ubiquitin E3 Ligase Complex Skp1-Pam-Fbxo45 Controls the Core Epithelial-to-mesenchymal Transition-Inducing Transcription Factors

miR-34a and IRE1A/XBP-1(S) Form a Double-Negative Feedback Loop to Regulate Hypoxia-Induced EMT, Metastasis, Chemo-Resistance and Autophagy

The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions